For the quarter ending 2025-09-30, CDIX had -$327,682 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Bad debt | - | - | - | 266,000 |
| Net loss | -1,144,299 | -1,226,395 | -450,777 | -910,342 |
| Depreciation | 762 | 763 | 3,365 | 3,365 |
| Right of use liabilities | - | - | - | 65,411 |
| Amortization of debt discounts | 0 | - | -24,821 | - |
| Right of use assets | - | - | - | -58,439 |
| Provision for credit losses | 0 | 0 | 112,727 | - |
| Amortization of debt discount | - | 0 | - | -1 |
| Change in estimate for settlement realization rate | 0 | - | - | 0 |
| Conversion and note issuance cost | 1,500 | 0 | 0 | 0 |
| Share issuance for compensation to directors and officers | - | - | - | 516,600 |
| Loss on disposal of assets | 0 | 0 | -12,593 | - |
| Interest included in line of credit | 1,713,188 | 1,441,975 | 1,137,308 | 1,138,683 |
| Gain on settlement of forgiveness of debt | 0 | 0 | - | 0 |
| Share issuance for compensation to directors and officers | 28,688 | 0 | -288,600 | - |
| Share issuance for service rendered | 12,500 | 97,500 | 0 | 16,500 |
| Accounts receivable | 1,506,580 | 1,691,365 | 1,680,291 | 1,401,628 |
| Right of use assets | -75,334 | -75,279 | -58,492 | - |
| Prepaids and other current assets | -4,965 | 2,771 | 19,593 | 97,866 |
| Due to related party | - | - | 0 | - |
| Accounts payable and accrued expense | 167,333 | -110,753 | 230,608 | -8,487 |
| Accrued officers compensation | 57,166 | 56,545 | 55,923 | -27,999 |
| Accrued interest | 90,946 | 35,438 | 101,773 | 68,028 |
| Right of use liabilities | -75,800 | -73,799 | -241,282 | - |
| Net cash used in operating activities | -574,297 | -1,397,583 | -491,420 | -722,559 |
| Net cash provided by discontinued operations operating | 0 | 0 | 0 | 0 |
| Payments to director | 0 | 0 | - | 0 |
| Proceeds from convertible notes payable | - | - | - | 0 |
| Repayment of sba loans | 2,193 | 2,193 | 2,193 | 2,194 |
| Net proceeds from line of credit | 323,808 | 1,037,733 | 427,186 | 38,338 |
| Payment on convertible notes | 0 | 0 | - | 0 |
| Payment on note payable | 75,000 | 75,000 | 75,000 | 75,000 |
| Payment of dividend on preferred stock | - | - | - | 100,000 |
| Payment of dividends on preferred stock | 0 | 0 | -50,000 | - |
| Net cash provided by financing activities | 246,615 | 960,540 | 299,993 | 2,975,727 |
| Net (decrease) increase in cash | -327,682 | -437,043 | -191,427 | -761,415 |
| Cash and cash equivalents at beginning of period | 1,188,185 | - | - | - |
| Cash and cash equivalents at end of period | 232,033 | - | - | - |
Cardiff Lexington Corp (CDIX)
Cardiff Lexington Corp (CDIX)